YTE reported $5.32B in Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US $ 612.77M 11.48M
Agenus AGEN:US $ 456.17M 14.87M
Agios Pharmaceuticals AGIO:US $ 1252.47M 83.39M
Alnylam Pharmaceuticals ALNY:US $ 3330.42M 103.13M
Amgen AMGN:US $ 59294M 98M
Biocryst Pharmaceuticals BCRX:US $ 510.54M 17.18M
Biogen BIIB:US $ 25081.4M 1467M
Biomarin Pharmaceutical BMRN:US $ 6145.84M 83.13M
Bluebird Bio BLUE:US $ 573.59M 82.52M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Cerulean Pharma CERU:US $ 49.19M 6.62M
Chemocentryx CCXI:US $ 419.39M 21.06M
Clovis Oncology CLVS:US $ 392.86M 58.67M
Cti Biopharma CTIC:US $ 134.53M 3.1M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Exelixis EXEL:US $ 2881.4M 227.29M
Gilead Sciences GILD:US $ 62870M 210M
Idera Pharmaceuticals IDRA:US $ 26.31M 3.83M
Intercept Pharmaceuticals ICPT:US $ 498.6M 4.76M
IONIS PHARMACEUT IONS:US $ 2456.13M 62.96M
Macrogenics MGNX:US $ 218.04M 53.4M
Mirati Therapeutics MRTX:US $ 1279.79M 141.51M
Moderna Inc MRNA:US 26.04B 1.57B
Nektar Therapeutics NKTR:US $ 861.99M 162.13M
Neurocrine Biosciences NBIX:US $ 2005.7M 138.8M
Newlink Genetics NLNK:US $ 85.45M 7.74M
Novartis NOVN:VX SF 122910M 2308M
Novartis NVS:US $ 122910M 2308M
Ptc Therapeutics PTCT:US $ 1804.06M 4.47M
Puma Biotechnology PBYI:US $ 193.65M 7.03M
Regeneron Pharmaceuticals REGN:US $ 27205.8M 857.1M
Sarepta Therapeutics SRPT:US $ 2996.85M 59.3M
Seattle Genetics SGEN:US $ 3630.34M 13.65M
Ultragenyx Pharmaceutical RARE:US $ 1320.63M 63.4M
Vertex Pharmaceuticals VRTX:US $ 15582.2M 1326.1M
YTE INCY:US $ 5319.04M 264.81M